InvestSMART

Universal Biosensors, Inc. (ASX: UBI) - Announcements

DELISTED - Current share price for UBI : $0.014

ASX company news and announcements for Universal Biosensors, Inc. (UBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Biosensors, Inc. (UBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Biosensors, Inc. (UBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Biosensors, Inc. (UBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Italy Tender Win for Xprecia Prime 21 Aug 2024 9:58AM $0.140 $0.014 fallen by 90%
$4 Universal Biosensors to host investor briefing and Q&A 7 Aug 2024 9:09AM $0.120 $0.014 fallen by 88.33%
$4 Half Year Results Presentation - 30 June 2024 2 Aug 2024 9:05AM $0.140 $0.014 fallen by 90%
$4 Appendix 4D and Half Year Results - 30 June 2024 2 Aug 2024 9:04AM $0.140 $0.014 fallen by 90%
$4 June 2024 Quarterly Activity Report and Appendix 4C 30 Jul 2024 4:07PM $0.140 $0.014 fallen by 90%
$4 UBI receives $3.8m R&D Tax Incentive Rebate 18 Jun 2024 11:53AM $0.145 $0.014 fallen by 90.34%
$4 Results of 2024 Annual General Meeting 30 May 2024 12:38PM $0.140 $0.014 fallen by 90%
$4 CEO's AGM address to Securityholders 30 May 2024 9:07AM $0.140 $0.014 fallen by 90%
$4 Change in substantial holding from HNG 29 May 2024 1:49PM $0.140 $0.014 fallen by 90%
$4 Acquisition of CDIs & Graham McLean App 3Y 29 May 2024 9:45AM $0.145 $0.014 fallen by 90.34%
$4 Appendix 3Y - Craig Coleman 28 May 2024 11:36AM $0.140 $0.014 fallen by 90%
$4 Change in substantial holding 10 May 2024 2:40PM $0.135 $0.014 fallen by 89.63%
$4 Appendix 3Y - Craig Coleman 10 May 2024 9:45AM $0.130 $0.014 fallen by 89.23%
$4 Appendix 3Y - Judith Smith 9 May 2024 10:54AM $0.135 $0.014 fallen by 89.63%
$4 Appendix 3Y - Graham McLean 9 May 2024 10:53AM $0.135 $0.014 fallen by 89.63%
$4 Top 20 and Distribution Schedule for Quoted Options 8 May 2024 10:07AM $0.160 $0.014 fallen by 91.25%
$4 Application for quotation of securities - UBI 8 May 2024 9:49AM $0.160 $0.014 fallen by 91.25%
$4 Application for quotation of securities - UBI 8 May 2024 9:46AM $0.160 $0.014 fallen by 91.25%
$4 Completion of Entitlement Offer 8 May 2024 9:33AM $0.160 $0.014 fallen by 91.25%
$4 Q1 2024 Results Presentation - 31 March 2024 2 May 2024 12:27PM $0.148 $0.014 fallen by 90.51%
$4 Q1 2024 Results 2 May 2024 12:25PM $0.148 $0.014 fallen by 90.51%
$4 March 2024 Quarterly Activity Report and Appendix 4C 30 Apr 2024 3:44PM $0.155 $0.014 fallen by 90.97%
$4 Notification of cessation of securities - UBI 19 Apr 2024 3:31PM $0.165 $0.014 fallen by 91.52%
$4 Entitlement Offer Opens and Despatch of Prospectus 19 Apr 2024 9:00AM $0.165 $0.014 fallen by 91.52%
$4 Update - Proposed issue of securities - UBI 11 Apr 2024 10:23AM $0.180 $0.014 fallen by 92.22%

51 - 75 of 640 results

Page 3 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.